Andrea Haupt|October 1, 2021FDA Approves QULIPTA™ (atogepant), Developed for the Preventive Treatment of Migraine
Andrea Haupt|September 30, 2021Payer KFF: Delta cases, hospitalizations lead to uptick in vaccinations